-
Je něco špatně v tomto záznamu ?
Transcriptome and proteome analysis of steady-state in a perfusion CHO cell culture process
V. Bertrand, DJ. Karst, A. Bachmann, K. Cantalupo, M. Soos, M. Morbidelli,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
30997936
DOI
10.1002/bit.26996
Knihovny.cz E-zdroje
- MeSH
- buněčné kultury metody MeSH
- CHO buňky MeSH
- Cricetulus MeSH
- glykosylace MeSH
- monoklonální protilátky analýza genetika MeSH
- perfuze metody MeSH
- proteom analýza genetika MeSH
- proteomika metody MeSH
- transkriptom * MeSH
- vysoce účinné nukleotidové sekvenování MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Long-term continuous protein production can be reached by perfusion operation. Through the continuous removal of waste metabolites and supply of nutrients, steady-state (SS) conditions are achieved after a certain transient period, where the conditions inside the reactor are not only uniform in space but also constant in time. Such stable conditions may have beneficial influences on the reduction of product heterogeneities. In this study, we investigated the impact of perfusion cultivation on the intracellular physiological state of a CHO cell line producing a monoclonal antibody (mAb) by global transcriptomics and proteomics. Despite stable viable cell density was maintained right from the beginning of the cultivation time, productivity decrease, and a transition phase for metabolites and product quality was observed before reaching SS conditions. These were traced back to three sources of transient behaviors being hydrodynamic flow rates, intracellular dynamics of gene expression as well as metabolism and cell line instability, superimposing each other. However, 99.4% of all transcripts and proteins reached SS during the first week or were at SS from the beginning. These results demonstrate that the stable extracellular conditions of perfusion lead to SS also of the cellular level.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025727
- 003
- CZ-PrNML
- 005
- 20201222155359.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/bit.26996 $2 doi
- 035 __
- $a (PubMed)30997936
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bertrand, Vania $u Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.
- 245 10
- $a Transcriptome and proteome analysis of steady-state in a perfusion CHO cell culture process / $c V. Bertrand, DJ. Karst, A. Bachmann, K. Cantalupo, M. Soos, M. Morbidelli,
- 520 9_
- $a Long-term continuous protein production can be reached by perfusion operation. Through the continuous removal of waste metabolites and supply of nutrients, steady-state (SS) conditions are achieved after a certain transient period, where the conditions inside the reactor are not only uniform in space but also constant in time. Such stable conditions may have beneficial influences on the reduction of product heterogeneities. In this study, we investigated the impact of perfusion cultivation on the intracellular physiological state of a CHO cell line producing a monoclonal antibody (mAb) by global transcriptomics and proteomics. Despite stable viable cell density was maintained right from the beginning of the cultivation time, productivity decrease, and a transition phase for metabolites and product quality was observed before reaching SS conditions. These were traced back to three sources of transient behaviors being hydrodynamic flow rates, intracellular dynamics of gene expression as well as metabolism and cell line instability, superimposing each other. However, 99.4% of all transcripts and proteins reached SS during the first week or were at SS from the beginning. These results demonstrate that the stable extracellular conditions of perfusion lead to SS also of the cellular level.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a monoklonální protilátky $x analýza $x genetika $7 D000911
- 650 _2
- $a CHO buňky $7 D016466
- 650 _2
- $a buněčné kultury $x metody $7 D018929
- 650 _2
- $a Cricetulus $7 D003412
- 650 _2
- $a glykosylace $7 D006031
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a perfuze $x metody $7 D010477
- 650 _2
- $a proteom $x analýza $x genetika $7 D020543
- 650 _2
- $a proteomika $x metody $7 D040901
- 650 12
- $a transkriptom $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Karst, Daniel J $u Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.
- 700 1_
- $a Bachmann, Alessia $u RBM S.p.A. Istituto di Ricerche Biomediche A.Marxer, Merck, Rome, Italy.
- 700 1_
- $a Cantalupo, Katia $u RBM S.p.A. Istituto di Ricerche Biomediche A.Marxer, Merck, Rome, Italy.
- 700 1_
- $a Soos, Miroslav $u Department of Chemical Engineering, University of Chemistry and Technology, Technicka 5, 166 28, Prague, Czech Republic.
- 700 1_
- $a Morbidelli, Massimo $u Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.
- 773 0_
- $w MED00000795 $t Biotechnology and bioengineering $x 1097-0290 $g Roč. 116, č. 8 (2019), s. 1959-1972
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30997936 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155355 $b ABA008
- 999 __
- $a ok $b bmc $g 1599872 $s 1116413
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 116 $c 8 $d 1959-1972 $e 20190507 $i 1097-0290 $m Biotechnology and bioengineering $n Biotechnol Bioeng $x MED00000795
- LZP __
- $a Pubmed-20201125